Susquehanna International Group
PVLA

Susquehanna International Group’s Palvella Therapeutics PVLA Stock Holding History

Susquehanna International Group’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05M Buy
+32,500
New +$3.39M ﹤0.01% 4632
2025
Q4 		– Sell
-5,100
Closed -$320K – 13958
2025
Q3 		$320K Buy
+5,100
New +$227K ﹤0.01% 9965
2022
Q3 		– Sell
-130
Closed -$19K – 14291
2022
Q2 		$19K Buy
+130
New +$23.7K ﹤0.01% 12380
2021
Q4 		– Sell
-2,596
Closed -$1.07M – 14061
2021
Q3 		$1.07M Buy
2,596
+811
+45% +$282K ﹤0.01% 7373
2021
Q2 		$547K Buy
+1,785
New +$391K ﹤0.01% 9366
2021
Q1 		– Sell
-279
Closed -$56K – 12949
2020
Q4 		$56K Buy
279
+11
+4% +$2.29K ﹤0.01% 10719
2020
Q3 		$44K Buy
+268
New +$61K ﹤0.01% 10237
2019
Q4 		– Sell
-914
Closed -$249K – 10823
2019
Q3 		$249K Buy
+914
New +$354K ﹤0.01% 8686
2019
Q1 		– Sell
-393
Closed -$84K – 10005
2018
Q4 		$84K Sell
393
-418
-52% -$130K ﹤0.01% 8294
2018
Q3 		$363K Sell
811
-387
-32% -$168K ﹤0.01% 7098
2018
Q2 		$486K Sell
1,198
-565
-32% -$269K ﹤0.01% 6854
2018
Q1 		$962K Buy
1,763
+1,504
+581% +$931K ﹤0.01% 5334
2017
Q4 		$156K Buy
259
+53
+26% +$24.6K ﹤0.01% 8461
2017
Q3 		$95K Buy
+206
New +$88K ﹤0.01% 8381

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna International Group's PVLA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Palvella Therapeutics (PVLA) in Q1 2026: 18,808 shares worth $2.34M. The stake represents ﹤0.01% of the portfolio and ranks #5798 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in PVLA as recently as Q3 2025.

Susquehanna International Group first reported a position in PVLA in Q2 2015 and has held it in 24 quarters since. The position peaked at $3.2M in Q1 2025. 180 funds tracked by Wall St. Rank hold PVLA as of Q1 2026.

  • Susquehanna International Group held 18,808 shares of Palvella Therapeutics worth $2.34M as of Q1 2026.
  • Palvella Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Palvella Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5798 holding.
  • Susquehanna International Group first reported a position in Palvella Therapeutics in Q2 2015 and has held it in 24 quarters since.
  • Susquehanna International Group's Palvella Therapeutics position peaked at $3.2M in Q1 2025.
  • 180 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.